BusinessUPDATE: Go Epic Health to Begin Clinical Studies for ProstadeBy Nasdaq OMXMar 29, 2018, 1:51 PM UTC
BusinessExosome Diagnostics Expands its Coverage Reach for EPI to an Additional 82 Million Covered Lives in the United StatesBy Nasdaq OMXFeb 23, 2018, 12:47 PM UTC
BusinessExosome Diagnostics Launches National Sales Team to Support Flagship Test, ExoDx®Prostate(IntelliScore)By Nasdaq OMXJan 3, 2018, 12:31 PM UTC
BusinessIt’s Not too Late to Show Your Blue for Men’s Health WeekBy Nasdaq OMXJun 16, 2017, 5:05 PM UTC
